UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new approach to analysis of intracellular proteins and subcellular localization using cellprofiler and imageJ in combination

Methods (San Diego, Calif.), 2022-07, Vol.203, p.233-241

2022

Volltextzugriff (PDF)

Nrf2 Expression Is Decreased in LRRK2 Transgenic Mouse Brain and LRRK2 Overexpressing SH-SY5Y Cells

Biological and Pharmaceutical Bulletin, 2023/01/01, Vol.46(1), pp.123-127

2023

Volltextzugriff (PDF)

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson’s disease-associated mutations

FEBS letters, 2011-07, Vol.585 (14), p.2165-2170

2011

Volltextzugriff (PDF)

Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells

International journal of molecular sciences, 2020-03, Vol.21 (5), p.1890

2020

Volltextzugriff (PDF)

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family

Annals of neurology, 2005-06, Vol.57 (6), p.918-921

2005

Volltextzugriff (PDF)

Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells

Pharmaceuticals (Basel, Switzerland), 2022-12, Vol.16 (1), p.5

2022

Volltextzugriff (PDF)

Dominant-negative effects of LRRK2 heterodimers: A possible mechanism of neurodegeneration in Parkinson’s disease caused by LRRK2 I2020T mutation

Biochemical and biophysical research communications, 2013-01, Vol.430 (2), p.560-566

2013

Volltextzugriff (PDF)

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses

Journal of neuroimmunology, 2016-03, Vol.292, p.1-8

2016

Volltextzugriff (PDF)

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2

Stem cell research, 2020-12, Vol.49, p.102073-102073, Article 102073

2020

Volltextzugriff (PDF)

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis

Biochemical and biophysical research communications, 2010-01, Vol.391 (1), p.242-247

2010

Volltextzugriff (PDF)

The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

Molecular neurodegeneration, 2012-04, Vol.7 (1), p.15-15, Article 15

2012

Volltextzugriff (PDF)

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families

Neuroscience letters, 2007-04, Vol.417 (1), p.21-23

2007

Volltextzugriff (PDF)

Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation

Stem cell research, 2017-10, Vol.24 (C), p.36-39

2017

Volltextzugriff (PDF)

I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule

Biochemical and biophysical research communications, 2009-12, Vol.390 (3), p.710-715

2009

Volltextzugriff (PDF)

Leucine‐rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase‐3β

The FEBS journal, 2014-01, Vol.281 (1), p.3-13

2014

Volltextzugriff (PDF)

Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3β

The FEBS journal, 2011-12, Vol.278 (24), p.4895-4904

2011

Volltextzugriff (PDF)

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway

Human molecular genetics, 2015-09, Vol.24 (17), p.4879-4900

2015

Volltextzugriff (PDF)

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen

Biochemical and biophysical research communications, 2010-02, Vol.392 (3), p.431-435

2010

Volltextzugriff (PDF)

Vulnerability to stress in mouse offspring is ameliorated when pregnant dams are provided a chewing stick during prenatal stress

Archives of oral biology, 2019-01, Vol.97, p.150-155

2019

Volltextzugriff (PDF)

Pathogenesis of Parkinson's disease through LRRK2 mutation

Seikagaku. The Journal of Japanese Biochemical Society, 2014-02, Vol.86 (1), p.92

2014

Volltextzugriff (PDF)

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation

Journal of neuroimmunology, 2010-12, Vol.229 (1), p.123-128

2010

Volltextzugriff (PDF)

Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3[beta]

The FEBS journal, 2014-01, Vol.281 (1), p.3

2014

Volltextzugriff (PDF)

Broad spectrum of dystonia associated with a novel thanatosis-associated protein domain-containing apoptosis-associated protein 1 mutation in a Japanese family with dystonia 6, torsion

Movement disorders, 2012-09, Vol.27 (10), p.1324-1325

2012

Volltextzugriff (PDF)

Stimulatory effect of [alpha]-synuclein on the tau-phosphorylation by GSK-3[beta]

The FEBS journal, 2011-12, Vol.278 (24), p.4895

2011

Volltextzugriff (PDF)

I2020T LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3beta signaling pathway

Parkinsonism & related disorders, 2016-01, Vol.22, p.e167-e167

2016

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(74)

Sprache

Englisch
(72)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Humans
(32)
Animals
(18)
Male
(16)
Female
(15)
Biochemistry & Molecular Biology
(14)
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
(13)
Mice
(13)
Biological And Medical Sciences
(12)
Protein-Serine-Threonine Kinases - Genetics
(12)
Neurosciences & Neurology
(11)
Medical Sciences
(10)
Parkinson's Disease
(10)
Phosphorylation
(10)
Aged
(9)
Mutation
(9)
Parkinson Disease - Genetics
(9)
Adult
(8)
Middle Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new approach to analysis of intracellular proteins and subcellular localization using cellprofiler and imageJ in combination

Nrf2 Expression Is Decreased in LRRK2 Transgenic Mouse Brain and LRRK2 Overexpressing SH-SY5Y Cells

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: Impairment of the kinase activity by Parkinson’s disease-associated mutations

Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family

Jietacin Derivative Inhibits TNF-α-Mediated Inflammatory Cytokines Production via Suppression of the NF-κB Pathway in Synovial Cells

Dominant-negative effects of LRRK2 heterodimers: A possible mechanism of neurodegeneration in Parkinson’s disease caused by LRRK2 I2020T mutation

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson’s disease carrying the I2020T mutation in LRRK2

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis

The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families

Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation

I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson’s disease, has a higher intracellular degradation rate than the wild-type molecule

Leucine‐rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase‐3β

Stimulatory effect of α‐synuclein on the tau‐phosphorylation by GSK‐3β

I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen

Vulnerability to stress in mouse offspring is ameliorated when pregnant dams are provided a chewing stick during prenatal stress

Pathogenesis of Parkinson's disease through LRRK2 mutation

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation

Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3[beta]

Broad spectrum of dystonia associated with a novel thanatosis-associated protein domain-containing apoptosis-associated protein 1 mutation in a Japanese family with dystonia 6, torsion

Stimulatory effect of [alpha]-synuclein on the tau-phosphorylation by GSK-3[beta]

I2020T LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3beta signaling pathway

Suchergebnisse filtern